PMID- 25174839 OWN - NLM STAT- MEDLINE DCOM- 20150630 LR - 20191113 IS - 1873-4251 (Electronic) IS - 1570-162X (Linking) VI - 12 IP - 5 DP - 2014 TI - 2 ,3 -Dialdehyde of ATP, ADP, and adenosine inhibit HIV-1 reverse transcriptase and HIV-1 replication. PG - 347-58 AB - The 2 3 -dialdehyde of ATP or oxidized ATP (oATP) is a compound known for specifically making covalent bonds with the nucleotide-binding site of several ATP-binding enzymes and receptors. We investigated the effects of oATP and other oxidized purines on HIV-1 infection and we found that this compound inhibits HIV-1 and SIV infection by blocking early steps of virus replication. oATP, oxidized ADP (oADP), and oxidized Adenosine (oADO) impact the natural activity of endogenous reverse transcriptase enzyme (RT) in cell free virus particles and are able to inhibit viral replication in different cell types when added to the cell cultures either before or after infection. We used UFLC-UV to show that both oADO and oATP can be detected in the cell after being added in the extracellular medium. oATP also suppresses RT activity and replication of the HIV-1 resistant variants M184V and T215Y. We conclude that oATP, oADP and oADO display anti HIV-1 activity that is at in least in part due to inhibitory activity on HIV-1 RT. FAU - Schachter, Julieta AU - Schachter J FAU - Valadao, Ana Luiza Chaves AU - Valadao AL FAU - Aguiar, Renato Santana AU - Aguiar RS FAU - Barreto-de-Souza, Victor AU - Barreto-de-Souza V FAU - Rossi, Atila Duque AU - Rossi AD FAU - Arantes, Pablo Ricardo AU - Arantes PR FAU - Verli, Hugo AU - Verli H FAU - Quintana, Paula Gabriela AU - Quintana PG FAU - Heise, Norton AU - Heise N FAU - Tanuri, Amilcar AU - Tanuri A FAU - Bou-Habib, Dumith Chequer AU - Bou-Habib DC FAU - Persechini, Pedro Muanis AU - Persechini PM AD - Instituto de Biofisica, Carlos Chagas Filho (IBCCF), Universidade Federal do Rio de Janeiro, Polo de Xerem, RJ, Brasil. julieta@biof.ufrj.br. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Netherlands TA - Curr HIV Res JT - Current HIV research JID - 101156990 RN - 0 (Anti-HIV Agents) RN - 54970-91-1 (2',3'-dialdehyde ATP) RN - 61D2G4IYVH (Adenosine Diphosphate) RN - 8L70Q75FXE (Adenosine Triphosphate) RN - EC 2.7.7.- (reverse transcriptase, Human immunodeficiency virus 1) RN - EC 2.7.7.49 (HIV Reverse Transcriptase) RN - K72T3FS567 (Adenosine) SB - IM MH - Adenosine/*pharmacology MH - Adenosine Diphosphate/*pharmacology MH - Adenosine Triphosphate/*analogs & derivatives/pharmacology MH - Anti-HIV Agents/*pharmacology MH - Cells, Cultured MH - HIV Infections/*drug therapy MH - HIV Reverse Transcriptase/*antagonists & inhibitors/metabolism MH - HIV-1/*drug effects/enzymology/physiology MH - Humans MH - Macrophages/virology MH - Virus Replication/*drug effects EDAT- 2014/09/02 06:00 MHDA- 2015/07/01 06:00 CRDT- 2014/09/02 06:00 PHST- 2014/01/26 00:00 [received] PHST- 2014/06/11 00:00 [revised] PHST- 2014/08/15 00:00 [accepted] PHST- 2014/09/02 06:00 [entrez] PHST- 2014/09/02 06:00 [pubmed] PHST- 2015/07/01 06:00 [medline] AID - CHRE-EPUB-61960 [pii] AID - 10.2174/1570162x12666140826105824 [doi] PST - ppublish SO - Curr HIV Res. 2014;12(5):347-58. doi: 10.2174/1570162x12666140826105824.